Stockscreener 앱 받기
5.20
5.26%
0.26
Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스
Lifecore Biomedical (LFCR) price target decreased by 25.71% to 6.63 - MSN
Amended Statement of Ownership (sc 13g/a) - ADVFN
Form 4Statement of changes in beneficial ownership of securities - ADVFN
Form S-8Securities to be offered to employees in employee benefit plans - ADVFN
Form POS AMPost-Effective amendments for registration statement - ADVFN
Form DEF 14AOther definitive proxy statements - ADVFN
If You Invested $1,000 in Lifecore Biomedical Inc (LFCR) - Stock Titan
Lifecore Biomedical Receives 'Hold' Rating from Analysts - National Today
LFCR.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Death Cross: Is Lifecore Biomedical Inc on track to beat earningsEarnings Beat & Daily Profit Focused Screening - baoquankhu1.vn
Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit - Sahm
Retail Surge: Is Lifecore Biomedical Inc trading at a discountWeekly Stock Report & Free Reliable Trade Execution Plans - baoquankhu1.vn
Inflation Data: Is Lifecore Biomedical Inc a strong candidate for buy and holdBear Alert & AI Enhanced Trading Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect - ACCESS Newswire
2026-04-07 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect | NDAQ:LFCR | Press Release - Stockhouse
Merger Talk: Is Lifecore Biomedical Inc forming bullish engulfing patterns2026 Pullbacks & Real-Time Buy Zone Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - GlobeNewswire Inc.
LFCR Should I Buy - Intellectia AI
LFCR PE Ratio & Valuation, Is LFCR Overvalued - Intellectia AI
LFCR Technical Analysis & Stock Price Forecast - Intellectia AI
When Should You Buy Lifecore Biomedical, Inc. (NASDAQ:LFCR)? - Yahoo Finance
LFCR News & Events - Intellectia AI
Landec Corp. (US5147661046.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical Transition period Earnings Call Transcript - MarketBeat
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Momentum Shift: Can Lifecore Biomedical Inc continue delivering strong returns2026 Trade Ideas & Intraday High Probability Alerts - baoquankhu1.vn
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Buybacks Report: Is Lifecore Biomedical Inc a top pick in the sectorNew Guidance & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Claim your share of the $3.75M Lifecore Biomedical securities class action settlement - Claim Depot
Lifecore Biomedical Earnings Call Signals Profitable Shift - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Lifecore signs two manufacturing deals with existing customer By Investing.com - Investing.com South Africa
Lifecore Biomedical (LFCR) to Release Earnings on Thursday - MarketBeat
Lifecore Biomedical, Inc. Common Stock (LFCR) Stock Price Today & Analysis - Gotrade
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Lifecore Biomedical Inks Two New Agreements with Existing US Customer - Contract Pharma
Lifecore signs two manufacturing deals with existing customer - Investing.com
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer - The Manila Times
LFCR: Barrington Research Maintains Outperform Rating with $5.50 Price Target | LFCR Stock News - GuruFocus
Lifecore Biomedical (NASDAQ:LFCR) Earns Outperform Rating from Barrington Research - marketbeat.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - accessnewswire.com
2026-03-24 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical signs third site transfer deal in five months By Investing.com - Investing.com Australia
Lifecore Biomedical Signs Commercial Manufacturing Services Agreement with Medical Aesthetics Company - MarketScreener
Lifecore Biomedical signs third site transfer deal in five months - Investing.com
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company - GlobeNewswire
Published on: 2026-03-23 12:54:24 - baoquankhu1.vn
Lifecore stock sinks as delayed launches push growth further out - MSN
2026-03-22 | Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation | NDAQ:LFCR | Press Release - Stockhouse
Aug Summary: Is Lifecore Biomedical Inc a strong candidate for buy and holdEarnings Overview Summary & Weekly Stock Performance Updates - baoquankhu1.vn
Rally Mode: Is Lifecore Biomedical Inc a top pick in the sector2026 Analyst Calls & High Accuracy Investment Signals - baoquankhu1.vn
Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029 - MarketBeat
1.06%
1.05%
자본화:
|
볼륨(24시간):